City

Beijing (1)

Condition

EphA2 Overexpression (1)

Lymphoma (1)

Solid Tumor, Adult (1)

TP53 R175H (1)

TP53 R248Q (1)

TP53 R249S (1)

TP53 R273H (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Chinese PLA General Hospital (1)

Collaborator

Zhejiang University (1)

Intervention

abraxane (1)

cyclophosphamide (1)

pd-1 antibody (1)

tp53-epha-2-car-dc (1)

Study Documents

Intervention Type

biological (1)

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

tp53 r175h

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Solid Tumor, Adult, Lymphoma, EphA2 Overexpression Trial in Beijing (TP53-EphA-2-CAR-DC, Abraxane, Cyclophosphamide)

Recruiting

Solid Tumor, Adult
+6 more

TP53-EphA-2-CAR-DC
+3 more

Beijing, Beijing, China

Biotherapeutic Department of Chinsese PLA Gereral Hospital

Nov 29, 2022